Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2676]

ESTRO 2026:AI tool for radiotherapy can support the global effort to eliminate cervical cancer

ESTRO 2026:AI tool for radiotherapy can support the global effort to eliminate cervical cancer

Novel molecular marker may improve prostate cancer treatment

Novel molecular marker may improve prostate cancer treatment

FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular residual disease

FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular...

Experimental drug shows promise for some patients with advanced prostate cancer

Experimental drug shows promise for some patients with advanced prostate cancer

Screening modestly reduces prostate cancer deaths

Screening modestly reduces prostate cancer deaths

ESTRO 2026: AI tool for radiotherapy can support the global effort to eliminate cervical cancer

ESTRO 2026: AI tool for radiotherapy can support the global effort to eliminate cervical cancer

ESTRO 2026: Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects

ESTRO 2026: Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side...

Urine test better than MRI for monitoring low-risk prostate cancer in new study

Urine test better than MRI for monitoring low-risk prostate cancer in new study

Preserving the neurovascular bundle during radical robotic prostatectomy: Tips and tricks

Preserving the neurovascular bundle during radical robotic prostatectomy: Tips and tricks

Researchers develop first blood test to map tumour “neighbourhoods,” improving prediction of therapy response

Researchers develop first blood test to map tumour “neighbourhoods,” improving prediction of therapy response

More from ecancer